Advertisement
Screener

Royalty Pharma plc (RPRX) Net Margin

Royalty Pharma plc (RPRX) Net Margin

  • 2026-06-30: Net Margin 2.65%.
  • 2026-03-31: Net Margin 46.73%.
  • 2025-12-31: Net Margin 34.44%.
  • 2025-09-30: Net Margin 47.30%.

Complete source-backed net margin history.

Available history
2018-12-31 to 2026-06-30
Data captured

Historical Net Margin

DateNet Margin
2026-06-302.65%
2026-03-3146.73%
2025-12-3134.44%
2025-09-3047.30%
2025-06-305.56%
2025-03-3142.12%
2024-12-3135.07%
2024-09-3096.33%
2024-06-3018.99%
2024-03-310.84%
2023-12-3182.93%
2023-09-3013.45%
2023-06-3042.29%
2023-03-3149.82%
2022-12-31-80.62%
2022-09-3024.88%
2022-06-3056.82%
2022-03-319.21%
2021-12-311.37%
2021-09-3017.40%
2021-06-3079.42%
2021-03-3112.06%
2020-12-3129.90%
2020-09-3053.98%
2020-06-3086.52%
2020-03-3114.22%
2019-12-31310.48%
2019-09-3088.09%
2019-06-3033.15%

Annual Net Margin

DateNet Margin
2025-12-3132.42%
2024-12-3137.95%
2023-12-3148.20%
2022-12-311.91%
2021-12-3127.07%
2020-12-3145.94%
2019-12-31129.45%
2018-12-3176.76%

Similar stocks

Stock NameCountryMarket CapPE Ratio
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64
Viatris Inc (VTRS)United States$20.008B-0.00
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
INSMED Inc (INSM)United States$26.566B-26.60
Zoetis Inc. (ZTS)United States$29.045B11.38
Jazz Pharmaceuticals plc (JAZZ)$15.333B16.07
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10
BIOMARIN PHARMACEUTICAL INC (BMRN)United States$11.879B151.80